Skip to content
Review

Rational design of PROTACs empowered by deep generative modeling: current advances and future perspectives.

Oct 2026 · International Journal of Biological Macromolecules · pp. 154986 · 0 citations · 123 references
Medicine

Abstract

Deep generative modeling (DGM) represents a transformative paradigm in proteolysis-targeting chimera (PROTAC) discovery, transitioning the field from empirical trial-and-error and computer-aided drug design (CADD) toward data-driven, autonomous candidate generation. PROTAC design presents a high-dimensional systems engineering challenge due to the intertwined complexities of ternary-complex cooperativity, linker conformational plasticity, and conflicting pharmacokinetic profiles. By systematic integration of machine learning architectures-spanning language models, graph neural networks, and diffusion frameworks-with target-aware optimization strategies, modern workflows facilitate the rational design of linkers, warheads, and tripartite chimeras. While data sparsity and multi-objective optimization remain key computational bottlenecks, closed-loop simulation pipelines and experimental validation are overcoming these challenges. We systematically review state-of-the-art DGM methodologies for de novo PROTAC generation and delineate future strategies for harnessing these generative models to produce clinically translatable degraders.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.